LIPIGON PHARMACEUTICALS AB revenue for the last year amounted to 1.54 M EUR, the most of which — 1.47 M EUR — came from its highest performing source at the moment, Lipid-related Drugs, the year earlier bringing 214.17 k EUR. The greatest contribution to the revenue figure was made by Sweden — last year it brought LIPIGON PHARMACEUTICALS AB 1.47 M EUR, and the year before that — 214.17 k EUR.